Randomized Trial of ARCON in Larynx Cancer

NCT00147732 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

345

Enrollment

OTHER

Sponsor class

Conditions

Larynx Carcinoma

Interventions

RADIATION: Accelerated radiotherapy
RADIATION: ARCON

Sponsor

Radboud University Medical Center

Collaborators

[object Object]